Beth A. Bartholomew, MD

Validation of a Predictive Risk Score for Radiocontrast-Induced Nephropathy following Percutaneous Coronary Intervention

08/01/2008

William W. O'Neill , MD;

Charanjit S. Rihal , MD, MBA, FSCAI;

Kimberly A. Skelding , MD, FACC, FAHA, FSCAI;

Patricia J.M. Best , MD;

Beth A. Bartholomew , MD;

Ryan J. Lennon , MS;

Percutaneous diagnostic and therapeutic cardiovascular procedures rely on intravascular use of iodinated radiocontrast agents for visualization in the cardiac catheterization laboratory. The use of radiocontrast agents has been associated...

Percutaneous diagnostic and...

08/01/2008

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8

November 8 ⁠–⁠ November 10

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Beth A. Bartholomew, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products